Synergism Between Circulating Tumor Necrosis Factor Receptor 2 and HbA(1c) in Determining Renal Decline During 5–18 Years of Follow-up in Patients With Type 1 Diabetes and Proteinuria

OBJECTIVE: We studied the serum concentration of tumor necrosis factor receptor 2 (TNFR2) and the rate of renal decline, a measure of the intensity of the disease process leading to end-stage renal disease (ESRD). RESEARCH DESIGN AND METHODS: A cohort of 349 type 1 diabetic patients with proteinuria...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Skupien, Jan, Warram, James H., Niewczas, Monika A., Gohda, Tomohito, Malecki, Maciej, Mychaleckyj, Josyf C., Galecki, Andrzej T., Krolewski, Andrzej S.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Diabetes Association 2014
Materias:
Pathophysiology/Complications
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4140154/
https://ncbi.nlm.nih.gov/pubmed/24898299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc13-1983
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares